- Time of issue:2019-08-08 00:00:00
Henan Chuangxin Biotechnology Co., Ltd. is a large-scale joint-stock group company integrating animal drug research and development, production, sales and after-sales service. The company has a registered capital of 10.1 million yuan and its subsidiaries (Chuangxin Bio, Youbo Bio, Xinbanghui). Hair, Chuangxin Foreign Trade, Chuangxin Aquaculture Division, Chuangxin Commerce, Kangmuyuan, Animal Star, Animal Husbandry,). In December 2012, the one-off high score passed the acceptance of eight production lines of the veterinary drug GMP of the Ministry of Agriculture. The production dosage forms involved multiple dosage forms such as powder powder, Chinese medicine extraction, large and small volume injection, disinfectant and microecological preparation. It is known as the GMP standard sample factory of Henan Province.
Chuangxin Bio-Group actively cooperates with universities and colleges. It has established long-term cooperative relations with South China Agricultural University, Nanjing Agricultural University, Henan Agricultural University, Peking University Private Economics College, Zhengzhou Animal Husbandry and other universities, and actively transforms scientific research achievements of universities and colleges. Combination, theory and production practice are combined. The company has 3 doctors, 17 masters, 83% of college graduates, and has established a highly educated and highly qualified professional team.
The company specializes in anti-virus research and development of traditional Chinese medicine for 17 years. It has always been committed to the research of animal-derived Chinese herbal medicine extracts. For the first time, it puts forward the idea of treating poisonous diseases of poultry and livestock with "toxic attack", and applies animal extracts of Chinese herbal medicines such as medlar and cantharidin to veterinary medicine preparations. To achieve the exact curative effect, the production of the national three new types of Jinkang injection and Qingjie mixture, Shumujia, etc. are new breakthroughs in the application of animal extracts.
In response to current food safety, the state has introduced relevant policies, the implementation of prescription drugs and non-prescription drugs, which imposes great restrictions on antibiotics. In order to meet the needs of the current large-scale farming, the company has set up a large-scale farm (group) drug center for large-scale farms with no anti-aquaculture. With traditional Chinese medicine as the main body, combined with modern technology, the Chinese medicine anti-virus as a breakthrough, created a new A “three-foster” and “four-defense” new-scale farms are healthy.
Under the new situation, Chuangxin Bio-Group has taken a unique approach and carried forward the traditional Chinese medicine quintessence of the motherland, and will surely emerge from the veterinary drug industry. Chuangxin people are willing to work together with the majority of veterinary medicine practitioners to work hard to create human food safety.
Scan the QR code to read on your phone